{"id":49873,"date":"2025-12-03T21:34:05","date_gmt":"2025-12-03T13:34:05","guid":{"rendered":"https:\/\/flcube.com\/?p=49873"},"modified":"2025-12-03T21:34:06","modified_gmt":"2025-12-03T13:34:06","slug":"new-radiomedicine-series-d-raises-800m-yuan-for-radiopharmaceuticals","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=49873","title":{"rendered":"New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals"},"content":{"rendered":"\n<p><strong>Chengdu New Radiomedicine Technology Co., Ltd.<\/strong> announced completion of its <strong>Series D financing round<\/strong>, raising <strong>800 million yuan<\/strong> (\u2248\u202fUS$111\u202fmillion) co\u2011led by <strong>Shenzhen Capital Group<\/strong> and <strong>PICC Capital<\/strong>, with participation from the <strong>AstraZeneca\u2011CICC Healthcare Industry Fund<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financing-summary-amp-investor-syndicate\">Financing Summary &amp; Investor Syndicate<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Round<\/th><th>Amount<\/th><th>Co\u2011Leads<\/th><th>Strategic Participant<\/th><\/tr><\/thead><tbody><tr><td><strong>Series D<\/strong><\/td><td>800 million yuan<\/td><td>Shenzhen Capital Group, PICC Capital<\/td><td>AstraZeneca\u2011CICC Healthcare Industry Fund<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-company-profile-amp-strategic-infrastructure\">Company Profile &amp; Strategic Infrastructure<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Founded<\/strong>: 2016<\/li>\n\n\n\n<li><strong>Business<\/strong>: R&amp;D, production, and sales of medical isotopes and radiopharmaceuticals<\/li>\n\n\n\n<li><strong>Flagship Asset<\/strong>: China&#8217;s <strong>first commercial 30MeV IKON proton accelerator<\/strong> for radionuclide production<\/li>\n\n\n\n<li><strong>Pipeline Focus<\/strong>: Yttrium\u201190 [\u2079\u2070Y] carbon microsphere injection and radionuclide\u2011conjugated biological monoclonal antibodies\/polypeptides<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-platform-amp-pipeline\">Technology Platform &amp; Pipeline<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Asset Category<\/th><th>Key Products<\/th><th>Application<\/th><\/tr><\/thead><tbody><tr><td><strong>Radioembolics<\/strong><\/td><td>Yttrium\u201190 [\u2079\u2070Y] carbon microsphere<\/td><td>Hepatocellular carcinoma, liver metastases<\/td><\/tr><tr><td><strong>RDCs<\/strong><\/td><td>Radionuclide\u2011conjugated antibodies\/peptides<\/td><td>Oncology (multiple solid tumors)<\/td><\/tr><tr><td><strong>Manufacturing<\/strong><\/td><td>30MeV IKON proton accelerator<\/td><td>Commercial\u2011scale isotope production<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-investment-thesis\">Market Context &amp; Investment Thesis<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Radiopharmaceutical Market<\/strong>: China market projected to reach <strong>\u00a530\u202fbillion<\/strong> by 2030, growing at <strong>>25\u202f% CAGR<\/strong><\/li>\n\n\n\n<li><strong>Vertical Integration<\/strong>: Proton accelerator provides end\u2011to\u2011end control from isotope production to radiopharmaceutical manufacturing<\/li>\n\n\n\n<li><strong>Strategic Validation<\/strong>: AstraZeneca\u2011CICC participation signals Big Pharma endorsement of China&#8217;s radiopharma ecosystem<\/li>\n\n\n\n<li><strong>Use of Proceeds<\/strong>: Accelerate clinical development, expand RDC pipeline, and scale commercial production capacity<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding New Radiomedicine&#8217;s development timelines, commercial prospects, and market expansion. Actual results may differ due to regulatory, competitive, and operational uncertainties.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chengdu New Radiomedicine Technology Co., Ltd. announced completion of its Series D financing round, raising&#8230;<\/p>\n","protected":false},"author":1,"featured_media":49876,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[20,4485],"class_list":["post-49873","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-finance","tag-new-radiomedicine-technology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Chengdu New Radiomedicine Technology Co., Ltd. announced completion of its Series D financing round, raising 800 million yuan (\u2248\u202fUS$111\u202fmillion) co\u2011led by Shenzhen Capital Group and PICC Capital, with participation from the AstraZeneca\u2011CICC Healthcare Industry Fund.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=49873\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"Chengdu New Radiomedicine Technology Co., Ltd. announced completion of its Series D financing round, raising 800 million yuan (\u2248\u202fUS$111\u202fmillion) co\u2011led by Shenzhen Capital Group and PICC Capital, with participation from the AstraZeneca\u2011CICC Healthcare Industry Fund.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=49873\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-03T13:34:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-03T13:34:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0303.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49873#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49873\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals\",\"datePublished\":\"2025-12-03T13:34:05+00:00\",\"dateModified\":\"2025-12-03T13:34:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49873\"},\"wordCount\":245,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49873#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/0303.webp\",\"keywords\":[\"Finance\",\"New Radiomedicine Technology\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=49873#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49873\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=49873\",\"name\":\"New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49873#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49873#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/0303.webp\",\"datePublished\":\"2025-12-03T13:34:05+00:00\",\"dateModified\":\"2025-12-03T13:34:06+00:00\",\"description\":\"Chengdu New Radiomedicine Technology Co., Ltd. announced completion of its Series D financing round, raising 800 million yuan (\u2248\u202fUS$111\u202fmillion) co\u2011led by Shenzhen Capital Group and PICC Capital, with participation from the AstraZeneca\u2011CICC Healthcare Industry Fund.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49873#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=49873\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49873#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/0303.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/0303.webp\",\"width\":1080,\"height\":608,\"caption\":\"New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49873#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals - Insight, China&#039;s Pharmaceutical Industry","description":"Chengdu New Radiomedicine Technology Co., Ltd. announced completion of its Series D financing round, raising 800 million yuan (\u2248\u202fUS$111\u202fmillion) co\u2011led by Shenzhen Capital Group and PICC Capital, with participation from the AstraZeneca\u2011CICC Healthcare Industry Fund.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=49873","og_locale":"en_US","og_type":"article","og_title":"New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals","og_description":"Chengdu New Radiomedicine Technology Co., Ltd. announced completion of its Series D financing round, raising 800 million yuan (\u2248\u202fUS$111\u202fmillion) co\u2011led by Shenzhen Capital Group and PICC Capital, with participation from the AstraZeneca\u2011CICC Healthcare Industry Fund.","og_url":"https:\/\/flcube.com\/?p=49873","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-12-03T13:34:05+00:00","article_modified_time":"2025-12-03T13:34:06+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0303.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=49873#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=49873"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals","datePublished":"2025-12-03T13:34:05+00:00","dateModified":"2025-12-03T13:34:06+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=49873"},"wordCount":245,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=49873#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0303.webp","keywords":["Finance","New Radiomedicine Technology"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=49873#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=49873","url":"https:\/\/flcube.com\/?p=49873","name":"New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=49873#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=49873#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0303.webp","datePublished":"2025-12-03T13:34:05+00:00","dateModified":"2025-12-03T13:34:06+00:00","description":"Chengdu New Radiomedicine Technology Co., Ltd. announced completion of its Series D financing round, raising 800 million yuan (\u2248\u202fUS$111\u202fmillion) co\u2011led by Shenzhen Capital Group and PICC Capital, with participation from the AstraZeneca\u2011CICC Healthcare Industry Fund.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=49873#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=49873"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=49873#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0303.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0303.webp","width":1080,"height":608,"caption":"New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=49873#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0303.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=49873"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49873\/revisions"}],"predecessor-version":[{"id":49877,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49873\/revisions\/49877"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/49876"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=49873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=49873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=49873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}